According to the Complaint, Cotiviti Holdings, Inc. ("Cotiviti" or the "Company") provides payment processing services in the United States, including claims management, clinical chart validation, optimization analysis, and other services.

On June 19, 2018, the Company and Veritas Capital jointly announced the Proposed Merger in a press release, pursuant to which each share of Cotiviti common stock will be exchanged for $44.75 in cash (the “Merger Consideration”), representing an enterprise value of approximately $4.9 billion.

The Complaint alleges that on July 23, 2018, in order to convince Cotiviti shareholders to vote in favor of the Proposed Merger, the Board authorized the filing of a materially incomplete and misleading Proxy Statement on Schedule 14A with the Securities and Exchange Commission, in violation of Sections 14(a) and 20(a) of the Exchange Act.

This case was voluntarily dismissed on November 14, 2018.